Skip to content

Hayman Rambaran, MD

NPI 1639295470ActiveIndividual· Internal Medicine, Addiction Medicine· Paramus, NJ

Internal Medicine, Addiction Medicine (MD) with Bergen County Improvement Authority and 1 other group, practicing in Paramus, New Jersey. Their prescriptions cost Medicare Part D more than their services did: $59,560 for 451 claims, against $5,466 paid for services in 2024. Braeburn Inc. was the largest of 7 companies reporting payments in 2025, $650.03 in all, mostly food and beverage. Lists Bergen New Bridge Medical Center as a hospital affiliation.

Overview

NPI1639295470
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedMar 22, 2007
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Addiction Medicine Primary207RA0401X25MA07140300NJ

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Addiction Medicine (NJ)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients33
Services billed39 across 2 procedure codes
Paid by Medicare$5,466

Part D prescriptions in 2024

Prescriptions (claims)451 · 455 30-day fills
Patients52
Total drug cost$59,560
Generic share94% of claims

Medicare sources and data years

Education and affiliations

Graduation year1985
Medicare specialtyAddiction Medicine
Secondary specialtiesInternal Medicine

Medical groups

Hospital affiliation

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$650.03 · 26 payments from 7 companies
  • 2024$731.25 · 18 payments from 5 companies

Top paying companies in 2025

CompanyAmountPayments
Braeburn Inc.$176.7411
Indivior Inc.$169.709
Gilead Sciences, Inc.$124.981
Neurocrine Biosciences, Inc.$108.271
Alkermes, Inc.$33.912

What the 2025 payments were for

  • Food and Beverage$650.03 · 26 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records